JFG protects rats from RA by reducing foot swelling, improving synovial pathology, and lowering TNF-α, IL-1β, and IL-6 levels via NLRP3 and TLR4/NF-κB inhibition. This evidence concerns the gene NFKB1 and rheumatoid arthritis.